Welcome. How can we help?
30 Day Trial
30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Subscribe to see current content

2014 Revenue: Zimmer

4Q14 revenue: $1,223MM, +2% Reconstructive $911MM, +2% (Americas $501MM, -1%; Europe $261MM, +5%; Asia Pacific $149MM, +7%) Knees $519MM, +2% (Americas $307MM, flat; Europe $134MM, +6%;...

2014 Revenue: Stryker

4Q14 revenue: Orthopaedics $1,110MM, +5% (U.S. +7%) Hips $331MM, +0.1% (U.S. +5%, ex-U.S. -5%) Knees $363MM, flat (U.S. flat) Trauma/Extremities $335MM, +13% (U.S. +19%; U.S...

2014 Revenue: CONMED

4Q14 revenue: $101.7MM, -4% (Sports Medicine -3%: U.S. -9%, ex-U.S. ~$61MM, -3%; Powered Instruments -2%: U.S. +1%) 2014 revenue: $402.8MM, -1% (Sports Medicine -1%: U.S. -8%, ex-U.S. ~$241.6MM...

2014 Revenue: Vexim

4Q14 revenue €2.9MM (~US $3.3MM), +44.5% 2014 revenue €10.3MM (~US $11.6MM), +68.5%   >8,000 SpineJack implants sold in 2014, +76% from 2013 (>17,000 since laun...

Will Orthopaedics Become a Consumer-driven Market?

What entity in the healthcare chain will hold the most power five years from now: hospital, surgeon, Medicare, insurance companies? This question was posed to each of the speakers at the symposium....

Page Navigation
First